India Cold Chain Pharmaceutical Packaging Market Size, Share, and COVID-19 Impact Analysis, By Material Type (Plastic, Corrugated Fibreboard, Metal, Glass, and Others), By Product Type (Insulated Shipper, Insulated Containers, Phase Change Materials, Temperature Monitoring Devices, and Refrigerants), By End User (Pharmaceutical Companies, Biotech Firms, Healthcare Providers, Clinical Research Organizations, and Cold Chain Logistics Companies), and India Cold Chain Pharmaceutical Packaging Market Insights, Industry Trend, Forecasts to 2035

India Cold Chain Pharmaceutical Packaging Market Size Insights Forecasts to 2035

• The India Cold Chain Pharmaceutical Packaging Market Size Was Estimated at USD 811.5 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 14.1% from 2025 to 2035
• The India Cold Chain Pharmaceutical Packaging Market Size is Expected to Reach USD 3,501.9 Million by 2035

According to A Research Report Published by Spherical Insights & Consulting, The India cold chain pharmaceutical packaging market Size is anticipated to reach USD 3,501.9 Million by 2035, growing at a CAGR of 14.1% from 2025 to 2035. The cold chain pharmaceutical packaging market in India is driven by the rising biologic & drug market, technological advancements, and a strict regulatory framework.

Market Overview

The Indian cold chain pharmaceutical packaging industry is experiencing rapid growth as a result of improved infrastructure and ease of doing business. The cold chain pharmaceutical packaging refers to a complicated blend of packaging designs, techniques, materials, performance validation techniques, and distribution strategies to ensure safe delivery of temperature-sensitive pharmaceutical products. It employs technically special containers, insulated systems, and a monitoring system for proper product preservation and delivery. Cold chain system mainly uses temperature-controlled packaging, which maintains the temperature of medicines within the specified limits and avoids damage from heat or cold, during customs checks & handovers.

India is a huge producer and supplier of generic medicine to the world, and its production mainly occurs in India and is then distributed globally. To ensure proper product delivery across continents, it highly depends on reliable cold chain packaging infrastructure. Its growing trade with parts of the world is also surging the market for pharmaceutical cold chain packaging. Indian companies are increasingly using phase change materials for pharmaceutical packaging as they maintain product temperature within the limits for longer hours without the need of external refrigerator. Moreover, integration of the Internet of Things (IOT) in cold chain packaging has advanced the industry. It provides real-time tracking, monitoring and data analysis.

Report Coverage

This research report categorizes the market for the India cold chain pharmaceutical packaging market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the India cold chain pharmaceutical packaging market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the India cold chain pharmaceutical packaging market.

Driving Factors

The cold chain pharmaceutical packaging market in India is driven by the rising biologic & drug market, technological advancements, and a strict regulatory framework. Increasing demand for special drugs, vaccines, and biologics from round global is fuelling the pharmaceutical cold chain packaging market in India. These medical supplies are very delicate, as sometimes they contain necessary living bodies for the treatment, which are very sensitive to temperature variations, thereby validated packaging solutions are essential. So, to avoid any damage and have a proper supply, pharmaceutical companies have partnered with a cold chain solution company.

Continuous innovations in insulation and cooling technologies in pharmaceutical cold chain packaging are helping companies to stay competitive and increase process effectiveness. Development of lightweight vacuum insulation panel, automated packaging supporting reducing energy consumption while providing effective thermal protection.

Strict regulatory guidelines from the Indian government and international agencies for temperature-controlled packaging have prompted manufacturers to invest in validated packaging that maintains thermal integrity between both origin and destination, and compliance with these guidelines is accepted by international agencies.

Restraining Factors

The cold chain pharmaceutical packaging market in India is mostly constrained by the high cost of packaging systems. Developing and maintaining temperature-controlled packaging, along with the use of newly developed materials, increases the cost. For a smaller cold chain logistics company or pharmaceutical manufacturer, to afford this advanced cold chain system is difficult.

Market Segmentation

The India cold chain pharmaceutical packaging market share is classified into material type, product type, and end user.

• The plastic segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The India cold chain pharmaceutical packaging market is segmented by material type into plastic, corrugated Fibreboard, metals, glass, and others. Among these, the plastic segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is because plastics are lightweight, versatile, and cost-effective. Its forms, such as polyethylene and polypropylene, are highly used for insulating containers.

• The insulated shipper segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The India cold chain pharmaceutical packaging market is segmented by product type into insulated shipper, insulated containers, phase change materials, temperature monitoring devices, and refrigerants. Among these, the insulated shipper segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The reason behind this is that they provide high efficacy for long-duration temperature maintenance. They are cost-effective, reduce spoilage, and are versatile in product accommodation.

• The pharmaceutical companies segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. 

The India cold chain pharmaceutical packaging market is segmented by end user into pharmaceutical companies, biotech firms, healthcare providers, clinical research organizations, and cold chain logistics companies. Among these, the pharmaceutical companies segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The reason behind this is that pharmaceutical companies’ products, such as vaccines and biologics, are highly sensitive to temperature, which creates a necessity for them to use a cold chain packaging system.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the India cold chain pharmaceutical packaging market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Snowman Logistics Ltd
• ColdEx Logistics Pvt Ltd
• Mahindra Logistics Ltd
• Blue Dart Express Ltd
• Coldman Logistics Pvt Ltd
• DHL Supply Chain Pvt Ltd
• Tessol
• Intelsius India
• Peli Bio Thermal

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments:

• In October 2025, Peli Bio Thermal launched Credo Vault, a new-designed bulk shipper for thermal reliability and real-time tracking of pharmaceutical product shipments.

Market Segment

This study forecasts revenue at the India, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the India cold chain pharmaceutical packaging market based on the below-mentioned segments:

India Cold Chain Pharmaceutical Packaging Market, By Material Type

• Plastic
• Corrugated Fibreboard
• Metal
• Glass
• Others

India Cold Chain Pharmaceutical Packaging Market, By Product Type

• Insulated Shipper
• Insulated Containers
• Phase Change Materials
• Temperature Monitoring Devices
• Refrigerants

India Cold chain pharmaceutical packaging Market, By End User

• Pharmaceutical Companies
• Biotech Firms
• Healthcare Providers
• Clinical Research Organisations
• Cold Chain Logistics Companies